Cnd Life Sciences Receives Third Nih Sbir Grant To Study Syn-One Test In Patients Diagnosed With Rem Sleep Behaviour Disorder
Cnd Life Sciences, An Innovative Medical Diagnostics Company Pioneering The Detection, Visualization, And Quantification Of Protein Deposition In Cutaneous Nerve Fibers, Has Been Awarded A $3 Million Phase Ii Small Business Innovation Research (Sbir) Grant From The National Institute Of Neurological Disorders And Stroke (Ninds) Of The National Institutes Of Health (Nih). This Is The Third Nih Sbir Phase Ii Award For The Company To Study And Advance The Clinical Application Of The Syn-One Test, The Only Commercially Available Test That Uses Skin Biopsies To Help Clinicians Diagnose A Synucleinopathy, A Family Of Neurodegenerative Diseases That Includes Parkinson
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!